The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global stem cell banking market reached a value of US$ 10.4 Billion in 2020. Looking forward, IMARC Group expects the market to reach a value of US$ 21.5 Billion by 2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Stem cell banking is one of the most promising as well as the fastest growing segment of the next-generation stem cell therapy. It is the process of extracting, freezing and storing stem cells for potential future use. Some of the sources through which stem cells are obtained include embryo, umbilical cord, cord blood, placenta and bone marrow. These cells are used for treating a number of different diseases including diabetes, thalassemia, leukemia, sickle cell anemia and cardiac diseases. Moreover, they are also employed for generating platelets, red blood cells and white blood cells. The potential of stem cells to regenerate has led to their applications in tissue engineering, gene therapy and regenerative medicines.
Global Stem Cell Banking Market Drivers:
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global stem cell banking market report, along with forecasts for growth at the global and regional level from 2021-2026. Our report has categorized the market based on product type, service type, bank type, utilization and application.
Breakup by Product Type:
On the basis of product types, the market has been segmented as adult stem cells, human embryonic cells and IPS cells. Presently, adult stem cells account for the majority of the market share as they help in repairing damaged tissues via cell division. In addition to this, adult stem cells offer advantages like ease of harvesting, high acceptance in the human body and effectiveness in tissue generation.
Breakup by Service Type:
Based on service types, the market has been segmented as sample preservation and storage, sample analysis, sample processing, and sample collection and transportation.
Breakup by Bank Type:
Based on the bank type, the market has been segregated as private and public stem cell banks. Private stem cell banks currently dominate the market, holding the largest share.
Breakup by Utilization:
Based on the utilization, the market has been segregated as used and unused.
Breakup by Application:
On the basis of application, the market has been segmented as personalized banking applications, research applications and clinical applications.
On a geographical front, North America enjoys the leading position in the global stem cell banking market on account of advancements in medical infrastructure and availability of federal funding for stem cell research. Other regions include Europe, Asia Pacific, Middle East and Africa, and Latin America.
The market is fragmented in nature with the presence various international as well as regional players. Some of the leading players operating in the market are:
|Base Year of the Analysis||2020|
|Segment Coverage||Product Type, Service Type, Bank Type, Utilization, Application, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Companies Covered||CBR Systems Inc., China Cord Blood Corporation, Cordlife, Cordvida, Cryo-Cell International, Inc., Cryo-Save AG (A Group of Esperite), Cryoviva India, Lifecell, Smart Cells International Ltd and Viacord|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
The global stem cell banking market size was valued at US$ 10.4 Billion in 2020.
The increasing consumer awareness towards numerous therapeutic benefits of stem cells represents one of the key drivers for the global stem cell banking market.
Several technological innovations in stem cell research activities represent one of the key trends in the global stem cell banking market.
Sudden outbreak of the COVID-19 pandemic had catalyzed the global market for stem cell banking as several healthcare providers are utilizing stem cells for managing severe symptoms.
On the basis of the product type, the market has been bifurcated into adult stem cells, human embryonic cells, and induced pluripotent stem (IPS) cells. Currently, adult stem cells account for the majority of the market share.
On the basis of the service type, the market has been segmented into sample preservation and storage, sample analysis, sample processing, and sample collection and transportation. Among these, sample preservation and storage represents the largest segment.
On the basis of the bank type, the market has been divided into private stem cell banks and public stem cell banks. Among these, private stem cell banks hold the majority of the total market share.
On the basis of the application, the market has been bifurcated into personalized banking applications, research applications and clinical applications. At present, personalized banking applications exhibit a clear dominance in the market.
Region-wise, the market has been classified into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America, where North America dominates the global market.
The key companies in the global stem cell banking market are CBR Systems Inc., China Cord Blood Corporation, Cordlife, Cordvida, Cryo-Cell International, Inc., Cryo-Save AG (A Group of Esperite), Cryoviva India, Lifecell, Smart Cells International Ltd., and Viacord.
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at